FDAClass IIMay 1, 2024

TRIDENTII HEMI CLUSTER54E- Indicated for use in primary recall

TRIDENTII HEMI CLUSTER54E- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 702-11-54E

Why was TRIDENTII HEMI CLUSTER54E- Indicated for use in primary recalled?

The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

UDI-DI:(01)07613327380880(17)290313(10) Lot Number: 15293151 15293153 15293152 15432252 15432254 15432451 15432351 15432251 15432253 16265752

Product
TRIDENTII HEMI CLUSTER54E- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 702-11-54E
Recalling firm
Howmedica Osteonics Corp.
Quantity
225 units
Distribution
Nationwide Foreign: Netherlands, Canada, Singapore, Spain, Sweden, UK
Recall date
May 1, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls